Formycon AG (FYB.DE)

EUR 53.4

(2.5%)

Net Income Summary of Formycon AG

  • Formycon AG's latest annual net income in 2023 was 75.79 Million EUR , up 110.59% from previous year.
  • Formycon AG's latest quarterly net income in 2024 Q2 was -10.09 Million EUR , down 0.0% from previous quarter.
  • Formycon AG reported an annual net income of 35.99 Million EUR in 2022, up 370.82% from previous year.
  • Formycon AG reported an annual net income of -13.29 Million EUR in 2021, down -124.28% from previous year.
  • Formycon AG reported a quarterly net income of 1.8 Million EUR for 2023 Q2, down 0.0% from previous quarter.
  • Formycon AG reported a quarterly net income of 73.99 Million EUR for 2023 Q4, down 0.0% from previous quarter.

Annual Net Income Chart of Formycon AG (2023 - 2009)

Historical Annual Net Income of Formycon AG (2023 - 2009)

Year Net Income Net Income Growth
2023 75.79 Million EUR 110.59%
2022 35.99 Million EUR 370.82%
2021 -13.29 Million EUR -124.28%
2020 -5.92 Million EUR -158.39%
2019 -2.29 Million EUR -132.31%
2018 7.09 Million EUR 548.89%
2017 -1.58 Million EUR 61.11%
2016 -4.06 Million EUR -804.07%
2015 577.51 Thousand EUR -32.87%
2014 860.32 Thousand EUR 111.11%
2013 -7.74 Million EUR -223.17%
2012 -2.39 Million EUR -85.68%
2011 -1.29 Million EUR -27.84%
2010 -1 Million EUR -428.3%
2009 -191 Thousand EUR 0.0%

Peer Net Income Comparison of Formycon AG

Name Net Income Net Income Difference
BioNTech SE 930.3 Million EUR 91.853%
CureVac N.V. -260.16 Million EUR 129.133%
Biotest Aktiengesellschaft 127 Million EUR 40.319%
Biotest Aktiengesellschaft 127 Million EUR 40.319%
BRAIN Biotech AG -8.27 Million EUR 1015.509%
Heidelberg Pharma AG -20.34 Million EUR 472.521%
Medigene AG -16.17 Million EUR 568.536%